- S&P 5007,561.67−0.40%
- Nasdaq 10027,943.74−1.22%
- NVDA$162.85−2.01%
- AAPL$356.27+0.39%
- MSFT$523.88+0.17%
- GOOGL$295.77−0.98%
- AMZN$266.66−0.29%
- META$641.69+2.90%
- TSLA$390.22−1.82%
- AVGO$347.01−4.76%
- AMD$534.06−8.75%
- MU$778.31−2.52%
Stock news
317 stories
Investment case changesPrimoris Services Corporation (NYSE: PRIM) Nears the End of Solar OverrunsFive of six troubled projects have reached mechanical completion, but final closeout still has to protect margins. PRIM · OptimistFi Research Desk · 
Market narrative auditsCan Meta Platforms, Inc. (NASDAQ: META) Win Enterprise AI?Meta has launched an enterprise AI platform, but the announcement includes no pricing, customers, bookings or revenue target. META · OptimistFi Research Desk · 
Market narrative auditsNVIDIA Corporation (NASDAQ: NVDA) Extends Its Stack to AI SafetyOpenShell enforces policy while a BlueField-4 watchdog can quarantine errant agents in milliseconds. NVDA · OptimistFi Research Desk · 
Investor guidesWhy Is AppLovin Corporation (NASDAQ: APP) Stock Down 54% This Year?Revenue and cash kept growing, but a rare miss turned the test toward whether AXON can keep outrunning larger ad platforms. APP · OptimistFi Research Desk · 
Market narrative auditsWhy Gold Fields Limited (NYSE: GFI) Stock Fell After Its Northern Star BidNorthern Star Resources Limited (ASX: NST) rejected the proposal. About 73% of the original per-share value was stock, creating a major dilution and execution test. GFI · OptimistFi Research Desk · 
Market narrative auditsNVIDIA Corporation (NASDAQ: NVDA) Expands Buyback to $235 BillionThe remaining authorization is 2.36 times NVIDIA's latest liquid assets. Continued cash generation must fund buybacks and a $366 billion commitment book. NVDA · OptimistFi Research Desk · 
Investment case changesVox Royalty Corp. (NASDAQ: VOXR) Bets $13 Million on Sorby HillsThe silver royalty could begin paying in 2027, but the purchase price equals about 42% of Vox Royalty Corp. (NASDAQ: VOXR)'s June cash balance. VOXR · OptimistFi Research Desk · 
Investment case changesKodiak Sciences Inc. (NASDAQ: KOD) Advances Zenkuda Toward FilingZenkuda matched aflibercept on vision at one year, and 54% of patients reached a six-month dosing interval. KOD · OptimistFi Research Desk · 
Market narrative auditsDoes Broadcom Inc. (NASDAQ: AVGO)'s $250M Sale Signal Trouble?Henry Samueli sold about $250 million of stock, but the plan was adopted nine months earlier and the sale was 0.84% of the filing's pre-transaction holdings. AVGO · OptimistFi Research Desk · 
Investment case changesApplied Digital Corporation (NASDAQ: APLD) Has 56% of Contracts With One CustomerOne investment-grade hyperscaler represents $20 billion of a $36 billion contract book. Nearly 80% of contracted power has investment-grade support. APLD · OptimistFi Research Desk · 
Market narrative auditsCoreWeave, Inc. (NASDAQ: CRWV) Has a $30 Million Rate TestA one-point rate move could change quarterly interest expense by about $30 million. The 10-year Treasury does not directly set CoreWeave's loan costs. CRWV · OptimistFi Research Desk · 
Market narrative auditsBiotech2k Tests Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM)'s FOP UpsideBiotech2k says Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM)'s Atebrioz is medically useful but financially modest. The patient pool, licensing costs and an existing rival explain why. MIRM · OptimistFi Research Desk ·
APP · OptimistFi Research Desk · 
GFI · OptimistFi Research Desk · 
KOD · OptimistFi Research Desk · 
APLD · OptimistFi Research Desk · 
CRWV · OptimistFi Research Desk · 
MIRM · OptimistFi Research Desk ·